Incidence of Respiratory Syncytial Virus in Community-Dwelling Adults Aged 18–64 Years Over 2 Seasons, 2022–2024, in a North American Community
Open Forum Infectious Diseases · 27.09.2024 · 11 (10)
DOI: 10.1093/ofid/ofae597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 11.10.2024. Verfasst von Wendelyn Bosch und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Mayo Clinic, Jacksonville, Florida, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GSK.
Abstract (Originalsprache)
Background
The incidence of respiratory syncytial virus (RSV)–acute respiratory infection (ARI) in community-dwelling adults after the Omicron variant of the COVID-19 pandemic is unknown. Our aim was to assess the incidence of RSV-ARI in adults aged 18 to 64 years over 2 consecutive RSV seasons (October–April 2022–2024) in 4 US states.
Methods
This community-based prospective cohort study comprised 7501 participants in Minnesota, Wisconsin, Florida, and Arizona. We calculated RSV-ARI and RSV–lower respiratory tract disease (LRTD) incidence and attack rates. We reported unadjusted incidence by age group, gender, race and ethnicity, Charlson Comorbidity Index, socioeconomic status, residential state, and rural/urban setting.
Results
Seasons 1 and 2 had 2250 and 2377 ARI episodes, respectively, with an RSV-ARI positivity rate of 5.5% for season 1 and 5.8% for season 2 among those tested. In season 1, the overall incidence of RSV-ARI was 27.71 (95% CI, 22.82–33.34) per 1000 person-years (1.49% attack rate). Almost half (49.0%) had RSV-LRTD, with an incidence of 13.53 (95% CI, 10.19–17.61) per 1000 person-years (0.73% attack rate). In season 2, the RSV-ARI and RSV-LRTD incidence rates were 26.39 (95% CI, 21.73–31.75) per 1000 person-years (1.51% attack rate) and 12.43 (95% CI, 9.31–16.26) per 1000 person-years (0.72% attack rate). RSV-ARI incidence peaked in November 2022 and December 2023.
Conclusions
Our observations suggest that RSV-ARI incidence and seasonal pattern are shifting to prepandemic RSV epidemiology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Mayo Clinic, Jacksonville, Florida, USA.
- Division of Infectious Diseases, Mayo Clinic, Phoenix, Arizona, USA.
- Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Community Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Wendelyn Bosch, Lisa J Speiser, Chung-Il Wi, Katherine S King, Joseph D Yao, Paul Y Takahashi, Brandon H Hidaka, Randy M Foss, Young J Juhn
Förderung
- GSK
Zitieren
APA
Bosch, W., Speiser, L. J., Wi, C. I., King, K. S., Natoli, T. L., Ihrke, K. D., Spiten, M. J., Binnicker, M. J., Yao, J. D., Takahashi, P. Y., Pignolo, R. J., Hidaka, B. H., Foss, R. M., Pirçon, J. Y., Saeedi, P., Oujaa, M., & Juhn, Y. J. (2024). Incidence of Respiratory Syncytial Virus in Community-Dwelling Adults Aged 18–64 Years Over 2 Seasons, 2022–2024, in a North American Community. Open Forum Infectious Diseases, 11(10). https://doi.org/10.1093/ofid/ofae597
Vancouver
Bosch W, Speiser LJ, Wi CI, King KS, Natoli TL, Ihrke KD, et al. Incidence of Respiratory Syncytial Virus in Community-Dwelling Adults Aged 18–64 Years Over 2 Seasons, 2022–2024, in a North American Community. Open Forum Infectious Diseases. 2024;11(10). doi:10.1093/ofid/ofae597
BibTeX
@article{Bosch2024,
author = {Bosch, Wendelyn and Speiser, Lisa J and Wi, Chung-Il and King, Katherine S and Natoli, Traci L and Ihrke, Kathy D and Spiten, Matthew J and Binnicker, Matthew J and Yao, Joseph D and Takahashi, Paul Y and Pignolo, Robert J and Hidaka, Brandon H and Foss, Randy M and Pirçon, Jean-Yves and Saeedi, Pouya and Oujaa, Mohamed and Juhn, Young J},
title = {Incidence of Respiratory Syncytial Virus in Community-Dwelling Adults Aged 18–64 Years Over 2 Seasons, 2022–2024, in a North American Community},
journal = {Open Forum Infectious Diseases},
year = {2024},
volume = {11},
number = {10},
doi = {10.1093/ofid/ofae597}
}
EUVIMED